*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Title: High Throughput, Label-free Enrichment of Circulating Tumor Cells Via Micromachined Polymer Devices
Committee:
Dr. Fatih Sarioglu, ECE, Chair, Advisor
Dr. Bruno Frazier, ECE
Dr. John McDonald, Biosciences
Dr. Levent Degertekin, ECE
Dr. Tobey McDonald, Emory
Abstract: Circulating tumor cells (CTCs) are the cells that detach from the primary tumor and intravasate into bloodstream of patients. CTCs are responsible for distant organ metastasis and inherit valuable information for the clinical management of the disease. While accessing these valuable tumor cells from bloodstream, called liquid biopsy, is easier and less invasive for patients compared to standard tissue biopsy, efficient enrichment of them from blood is a technical challenge. CTCs are mixed with approximately billion times more populated blood cells in circulation. Moreover, heterogeneity of tumor cells, a major cause of failure in prognosis and prediction, necessitates extremely sensitive technologies for isolation and downstream analyses. Besides single CTCs, even more rare aggregates of CTCs, called CTC clusters, also contribute to cancer metastasis with a much greater metastatic propensity. In addition to the aforementioned challenges, enrichment of CTC clusters requires gentle operating conditions due to fragility of these aggregates. In this thesis, we present two distinct technologies for efficient enrichment and molecular analysis of CTCs and CTC clusters, and their use with clinical samples. First, we introduce the “Cluster-Wells” which combines the throughput and practicality of membrane filtration with the sensitive and deterministic screening afforded by microfluidic chips for gentle isolation of CTC clusters at 25 mL/h blood processing rate. Then, we introduce the "Sacrificial Biochip" technology for isolation and lossless retrieval of single CTCs from unprocessed whole blood, which allows direct integration of the developed assay with downstream analyses owing to the vanishing feature of the device. Efficient and gentle isolation of CTCs and CTC clusters has a great potential for the acceleration of research on their role in diagnosing, monitoring, and treating cancer.
